Primary amenorrhea is usually caused by genetic or anatomical abnormalities. The most common cause is gonadal dysgenesis, occurring in 43% of primary amenorrhea cases. Other common causes include Müllerian agenesis (15%), physiological delay of puberty (14%), polycystic ovary syndrome (7%), and isolated gonadotropin releasing hormone deficiency (5%). Secondary amenorrhea can be caused by decreased ovarian function (hypogonadism) due to low gonadotropin stimulation (hypogonadotropic hypogonadism) or primary ovarian failure (hypergonadotropic hypogonadism). Functional hypothalamic amenorrhea is a common cause of acquired secondary
AMENORRHEA
Ludmila Barbakadze
Ivane Javakhishvili Tbilisi State University Assistant Professor Medical Doctor at Archil Khomassuridze Institute of Reproductology ,Tbilisi , Georgia.
AMENORRHEA
Ludmila Barbakadze
Ivane Javakhishvili Tbilisi State University Assistant Professor Medical Doctor at Archil Khomassuridze Institute of Reproductology ,Tbilisi , Georgia.
Secondary amenorrhoea by dr alka mukherjee dr apurva mukherjeealka mukherjee
The first step in the evaluation of any patient with secondary amenorrhea is a urine pregnancy test. Every contraceptive method has a failure rate, and anyone who is menstruating is potentially fertile, regardless of age. [5][6]
If the pregnancy test is negative, consider the clinical picture: hirsutism, acne, and a long history of infrequent and irregular menses suggest polycystic ovarian syndrome. By the Rotterdam criteria, a patient may be diagnosed with PCOS if she has two of the following: clinical or chemical hyperandrogenism, oligo- or amenorrhea, or polycystic ovaries on ultrasound. So if a patient has evidence of hirsutism and oligo- or amenorrhea, she can be diagnosed with PCOS without further laboratory testing or imaging.
If history and physical exam are not consistent with PCOS, a TSH should be ordered. Both hyper- and hypothyroidism can lead to menstrual dysfunction.
If TSH is normal, check a serum prolactin. Elevated serum prolactin suggests prolactinoma.
it describes in detail about causes, investigations and management of female infertility.in the end of presentation, it includes a video demonstration to describe the management options of assisted conception.
Science, practice and evidence are dynamic processes. This is typically vivid when it relates to Polycystic Ovarian Syndrome. PCOS is the commonest hyperandrogenic disorder in women and one of the most common causes of ovulatory infertility. Although polycystic ovaries were first described by the Italian scientist Vallisneri in 1721, it was largely forgotten until the 1930s, and then renamed after its rediscoverers as Stein-Leventhal syndrome. Even then, it still wasn’t until the invention of the ultrasound scanner in the 1980s and consensus of diagnosis in the early 1990s that PCOS was recognized on a wider scale in women of reproductive age. When attempting to diagnose with precision something that is complex, it is important that we first clearly define what it is we are trying to diagnose. PCOS is today seen as a heterogeneous syndrome where a range of symptoms may be present or absent, and may overlap with other conditions, it is perhaps best viewed as a spectrum of symptoms, pathologic findings and laboratory abnormalities. PCOS can be difficult to conceptualize, even for experts, as shown by the fact that there have been several different ways of diagnosing it over the years.
More recently, the fundamental role of hyperandrogenism has been pointed out.
However, PCOS compromises other pathological conditions that strongly modify the phenotype and play a dominant role in the pathophysiology of the disorder, including insulin resistance and hyperinsulinemia, obesity and metabolic disorders, all favoring together with androgen excess, an increased susceptibility to develop type 2 diabetes mellitus (T2DM) and, possibly, cardiovascular diseases. PCOS by itself may also have some genetic component as documented by familial aggregation and recent genetic studies. All the clinical features may however change throughout the lifespan, starting from adolescence to postmenopausal age. Therefore, PCOS should be considered as a lifetime disorder.
I sincerely hope that with the recommended readings attached and lecture, you will be able to strengthen your knowledge, thereby providing evidence-based medicine practice for the management of PCOS in a successful manner to improve and better women’s Health care. The best investment you can make is an investment in yourself. The more you learn, the more you’ll earn (Warren Buffett), so read as much as you can.
Thank You.
Regards: Rafi Rozan
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Secondary amenorrhoea by dr alka mukherjee dr apurva mukherjeealka mukherjee
The first step in the evaluation of any patient with secondary amenorrhea is a urine pregnancy test. Every contraceptive method has a failure rate, and anyone who is menstruating is potentially fertile, regardless of age. [5][6]
If the pregnancy test is negative, consider the clinical picture: hirsutism, acne, and a long history of infrequent and irregular menses suggest polycystic ovarian syndrome. By the Rotterdam criteria, a patient may be diagnosed with PCOS if she has two of the following: clinical or chemical hyperandrogenism, oligo- or amenorrhea, or polycystic ovaries on ultrasound. So if a patient has evidence of hirsutism and oligo- or amenorrhea, she can be diagnosed with PCOS without further laboratory testing or imaging.
If history and physical exam are not consistent with PCOS, a TSH should be ordered. Both hyper- and hypothyroidism can lead to menstrual dysfunction.
If TSH is normal, check a serum prolactin. Elevated serum prolactin suggests prolactinoma.
it describes in detail about causes, investigations and management of female infertility.in the end of presentation, it includes a video demonstration to describe the management options of assisted conception.
Science, practice and evidence are dynamic processes. This is typically vivid when it relates to Polycystic Ovarian Syndrome. PCOS is the commonest hyperandrogenic disorder in women and one of the most common causes of ovulatory infertility. Although polycystic ovaries were first described by the Italian scientist Vallisneri in 1721, it was largely forgotten until the 1930s, and then renamed after its rediscoverers as Stein-Leventhal syndrome. Even then, it still wasn’t until the invention of the ultrasound scanner in the 1980s and consensus of diagnosis in the early 1990s that PCOS was recognized on a wider scale in women of reproductive age. When attempting to diagnose with precision something that is complex, it is important that we first clearly define what it is we are trying to diagnose. PCOS is today seen as a heterogeneous syndrome where a range of symptoms may be present or absent, and may overlap with other conditions, it is perhaps best viewed as a spectrum of symptoms, pathologic findings and laboratory abnormalities. PCOS can be difficult to conceptualize, even for experts, as shown by the fact that there have been several different ways of diagnosing it over the years.
More recently, the fundamental role of hyperandrogenism has been pointed out.
However, PCOS compromises other pathological conditions that strongly modify the phenotype and play a dominant role in the pathophysiology of the disorder, including insulin resistance and hyperinsulinemia, obesity and metabolic disorders, all favoring together with androgen excess, an increased susceptibility to develop type 2 diabetes mellitus (T2DM) and, possibly, cardiovascular diseases. PCOS by itself may also have some genetic component as documented by familial aggregation and recent genetic studies. All the clinical features may however change throughout the lifespan, starting from adolescence to postmenopausal age. Therefore, PCOS should be considered as a lifetime disorder.
I sincerely hope that with the recommended readings attached and lecture, you will be able to strengthen your knowledge, thereby providing evidence-based medicine practice for the management of PCOS in a successful manner to improve and better women’s Health care. The best investment you can make is an investment in yourself. The more you learn, the more you’ll earn (Warren Buffett), so read as much as you can.
Thank You.
Regards: Rafi Rozan
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Amenorrhea.pptx
1. Amenorrhea
• Normal menses require adequate ovarian production of steroid hormones
• The endometrium must be able to respond normally to hormonal stimulation,
and the cervix, vagina, and introitus must be present and patent.
Definition
• Amenorrhea has classically been defined as primary (no prior menses) or
secondary (cessation of menses).
• Primary amenorrhea is defined as absence of menses at age 13 years when
there is no visible development of secondary sexual characteristics or age 15
years in the presence of normal secondary sexual characteristics.
2. Prevalence
• Pathologic amenorrhea
o3 to 4 % in reproductive-aged populations
• Physiologic amenorrhea
oPrior to puberty
oPregnancy and lactation
oMenopause
oContinuous COCs administration
3. Definition
• Primary amenorrhea is defined as the absence of menses at age 15
years in the presence of normal growth and secondary sexual
characteristics. ( up to date 2018)
• Secondary amenorrhea is absence of menses for more than three
months in girls or women who previously had regular menstrual
cycles or six months in girls or women who had irregular menses.
4. Secondary amenorrhea for 3 months or oligomenorrhea involving fewer than nine cycles a year is also
investigated (American Society For Reproductive Medicine, 2008).
Evaluation is considered for an adolescent:
(1) who has not menstruated by age 15 or within 3 years of thelarche or
(2) has not menstruated by age 14 and shows signs of hirsutism, excessive exercise, or eating disorder
(ACOG-2017)
5. CLASSIFICATION SYSTEM
• Decreased ovarian function (hypogonadism) may result either from a
lack of stimulation by the gonadotropins (hypogonadotropic
hypogonadism) or from primary failure of the ovary
(hypergonadotropic hypogonadism)
6.
7. ANATOMIC DISORDERS
Inherited Disorder
• It is frequent in adolescents, and pelvic anatomy is abnormal
in approximately 15 percent of women with primary amenorrhea
9. A. Gonadal dysgenesis- 43 percent
B. Müllerian agenesis -15 percent
C. Physiological delay of puberty (constitutional or illness -14 percent)
D. Polycystic ovary syndrome (PCOS) – 7 percent
E. Isolated GnRH deficiency – 5 percent (extremely rare)
F. Transverse vaginal septum – 3 percent
G. Weight loss/anorexia nervosa – 2 percent
H. Hypopituitarism – 2 percent
*What is the most common etiology for primary amenorrhea?
*In a large case series of primary amenorrhea, up to date 2018
10.
11.
12. Lower Outflow Tract Obstruction
• Amenorrhea is associated with imperforate hymen (1 in 2000
women), a complete transverse vaginal septum (1 in 70,000
women), or isolated vaginal atresia
• Thus , the amount of uterine bleeding is normal, but
its normal path or egress is obstructed or absent
• Moreover, in women with out flow blockage, an increase in
retrograde menstruation may lead to endometriosis development
Patients with out flow obstruction have a 46,XX karyotype, female secondary sexual characteristics,
and normal ovarian function
14. Anatomic defects that may lead to amenorrhea.
the müllerian ducts give rise
to the upper vagina, cervix, uterine
corpus, and fallopian tubes.
In complete müllerian agenesis, of
ten called
Mayer-Rokitansky-Kuster-Hauser
syndrome, patients fail to
develop any müllerian structures, and
examination reveals only a vaginal
dimple
16. Acquired Disorders
Cervical Stenosis
Stenosis most commonly involves the internal os
• Causes may be:
D and C
Conization
LEEP
Infection
Neoplasia
Radiation
17. Intrauterine Adhesions
Asherman syndrome
In a series of 1856 women with
Asherman syndrome, 88 percent
followed postabortal or postpartum
uterine curettage
Destruction of the basal endometrium
Causes may be:
• vigorous curettage
• Miscarriage complicated by infection
• Metroplasty, myomectomy, or
cesarean delivery, or infection related
to an intrauterine device
• tuberculous endometritis
• Diagnosis can be made with either
HSG or SIS
• Definitive diagnosis requires
hysteroscopy
• HSG is used to concomitantly asses
tubal patency
• Intrauterine adhesions
characteristically appear as irregular,
angulated filling defects within the
cavity
• Rx-hysteroscopic lysis of adhesions
18. HYPERGONADOTROPIC HYPOGONADISM
• It implies primary dysfunction within the ovary rather than
hypothalamic or pituitary dysfunction
• It can also be termed premature ovarian failure (POF)
19. Premature ovarian failure
• POF is defined as loss of oocytes and the surrounding support cells
prior to age 40 years.
• The diagnosis is determined by two serum FSH levels that measure
greater than a threshold range of 30 to 40 mIU/mL and are obtained
at least 1 month apart.
21. Heritable Disorders
Gonadal Dysgenesis
In general, approximately 90 percent of individuals with gonadal dysgenesis
from a loss of X genetic material never menstruate
the most frequent cause of POF
oocytes undergo accelerated atresia
The karyotype can be normal or abnormal
Normal…46 xx or 46 xy
Abnormal… 45 x-Turner syndrome and chromosomal mosaics
22. Specific Genetic Defects
Single gene mutations
fragile X mental retardation
CYP17 mutations
• Affected patients have sexual infantilism and
primary amenorrhea due to absent estrogen secretion.
• Sexual infantilism describes patients with a lack of breast development,
absent pubic and axillary hair, and a small uterus.
FSH or LH hormone gene mutations
galactosemia is a rare cause of POF.
23. Acquired Abnormalities
• Infection(e.g. mumps oophoritis), environmental exposures(cigarette
smoking, heavy metals, solvents,
pesticides, and industrial chemicals)
, autoimmune disease, or medical treatments.
• Autoimmune disorders account for an estimated 40 percent
of POF cases
• Iatrogenic ovarian failure is relatively common.
• Surgery related to ovary , chemotherapy ,radiotherapy
• POF 20 to Chemotherapy or radiotherapy depends on dose,pt’s age ,drug
choice(e.g. Alkylating agents)
24. HYPOGONADOTROPIC HYPOGONADISM
• It implies that the primary abnormality lies in the hypothalamic-
pituitary axis.
• Poor gonadotropin stimulation of the ovaries leads to
impaired follicular development
25. Hypothalamic Disorders
Inherited Hypothalamic Abnormalities
• Idiopathic hypogonadotropic hypogonadism (IHH)
• Kallmann syndrome- hyposmia or anosmia
• Anosmin-1 is critical for normal migration of both GnRH and olfactory
neurons
• KS is also associated with midline facial
anomalies such as cleft palate, unilateral renal agenesis, cerebellar ataxia,
epilepsy, neurosensory hearing loss, and synkinesis
• Kallmann syndrome can be distinguished from IHH by olfactory testing
26.
27. Acquired Hypothalamic Dysfunction
• Acquired hypothalamic abnormalities are much more frequent
than inherited deficiencies.
• Also called “hypothalamic amenorrhea’’
• encompasses three main categories: eating disorders, excessive
exercise, and stress.
28. Eating Disorders.
• Both anorexia nervosa and bulimia can lead to amenorrhea.
• Hypothalamic dysfunction is severe in anorexia and may affect
other hypothalamic-pituitary axes
29. Exercise induced Amenorrhea
• Significant loss of fat 20 to ballet, gymnastics, and long-distance
running
• Puberty may be delayed in girls who begin training before menarche
30. Female athlete triad
It consists of:
• Menstrual dysfunction
• Low energy availability and
• Low bone mineral density
32. Functional Hypothalamic Amenorrhea pathophysiology
It must be emphasized that
each cause of functional
hypothalamic amenorrhea
may act via one or all of
these pathways.
Opioids alter GnRH pulsatility
Primarily produced in adipose
tissue, leptin provides an
important link between energy
balance and reproduction
Patients with anorexia nervosa
have been found to have low
circulating leptin levels
Leptin has
been termed a
“satiety actor”
33. Pseudocyesis
• Pseudocyesis is considered in any woman with amenorrhea and
pregnancy symptoms.
• A common link in these patients is a history of severe grief ,
such as recent miscarriage, infant death, or longstanding infertility
34. Anatomic Destruction
• Any process that destroys the hypothalamus can impair GnRH secretion
and lead to hypogonadotropic hypogonadism and amenorrhea
• craniopharyngiomas, germinomas, endodermal sinus tumors,
eosinophilic granuloma (Hand-Schuller-Christian syndrome),
gliomas, and metastatic lesions
• The most common of these
tumors, craniopharyngiomas, are located in the suprasellar region and
frequently present with headaches and visual changes.
• Alternatively, impaired GnRH secretion may follow
trauma, radiation, infections such as tuberculosis, or infiltrative
diseases such as sarcoidosis
35. Anterior pituitary Gland Disorders
Inherited Abnormalities
• Different types of mutation
Acquired Pituitary Dysfunction
Most pituitary dysfunction is acquired after menarche and
there fore presents with normal pubertal development followed
by secondary amenorrhea.
36. Acquired Pituitary Dysfunction….
• Pituitary adenomas are the most frequent cause of acquired
pituitary dysfunction
• Significantly elevated serum prolactin levels (> 100 ng/
mL) are almost always due to a pituitary mass
• Pituitary tumors also may indirectly alter gonadotrope function by a
mass effect
• pituitary function may also be diminished by inflammation, infiltrative
disease, metastatic lesions,surgery, or radiation treatment
• pituitary apoplexy-Spontaneous hemorrhage into a pituitary
adenoma
37. Acquired pituitary dysfunction….
• Sheehan syndrome refers to panhypopituitarism.
• It classically follows massive postpartum hemorrhage and associated
hypotension.
• The abrupt, severe hypotension leads to pituitary ischemia and
necrosis
40. Nonclassic congenital adrenal hyperplasia
• Also termed adult-onset CAH or late-onset CAH
• It is due to a mutation in the CYP21A2 gene, which encodes the 21-
hydroxylase enzyme
• Patients are unable to convert progesterone to cortisol and aldosterone, thus
increasing the production of androgens
• Result in anovulation and amenorrhea
• Mimics the presentation of PCOS with hyperandrogenism and irregular
menstrual cycles
41. Hyperprolactinemia and Thyroid Disorders
• TRH prompts pituitary gland thyrotropes to produce TSH.
• In addition, TRH also binds to pituitary lactotropes, increasing
prolactin secretion.
• This tight link between thyroid function and prolactin levels
justifies measurement of a TSH with prolactin levels when
initiating evaluation for galactorrhea or amenorrhea.
42. ….
• Classically, hypothyroidism is stated to cause anovulation
and subsequent heavy menstrual bleeding
• Hyperthyroidism is implicated in amenorrhea
• Nevertheless,
these patterns are not strictly observed
43. EVALUATION
• History
• Detailed menstrual hx
• Uterine or ovarian surgery
• Hx of postoperative infection
• Review of symptoms(new-onset headaches or visual changes)
• Bilateral milky breast discharge may reflect hyperprolactinemia
• heat or cold intolerance, weight
changes, and sleep or bowel motility abnormalities..thyroid disease
44. History..
• Hirsutism and acne are often seen with PCOS or with nonclassic CAH
• Cyclic pelvic pain would suggest a reproductive tract outlet
obstruction
• Hot flushes and vaginal dryness point to hypergonadotropic
hypogonadism, that is, POF
• Family history include premature cessation of menses or a history of
autoimmune disease, including thyroid disease, which would suggest an
increased risk or POF
45. History…
• A history of irregular menses, infertility, or signs
of excess androgen production is often noted with PCOS.
• Sudden neonatal death may have occurred in family members
carrying mutations in the CYP21A2 gene responsible for CAH
• Drug and evironmetal toxin exposure( smoking,antipsychotics …)
• antipsychotics increase prolactin levels.
46. Physical Examination
• General appearance
• Eating disorder…low BMI+tooth enamel
erosion
• Signs of Turner syndrome are evaluated, including short stature,
webbed neck, shield-shaped chest
• cleft palate…. developmental defect of the anterior pituitary gland.
• Hypertension…. mutation in the CYP17 gene and shunting of the
steroidogenic pathway toward aldosterone
• Visual field defects…. pituitary gland or CNS tumor
47. p/e…
• Skin is inspected for acanthosis nigricans, hirsutism, or acne, which may indicate
PCOS or other hyperandrogenism causes
• Supraclavicular fat, abdominal striae, and hypertension may be noted in those
with Cushing syndrome.
• Hypothyroidism can present with an abnormally enlarged thyroid gland, delayed
reflexes, and bradycardia.
• Sparse or absent axillary or pubic hair may reflect either lack
of adrenarche or androgen insensitivity syndrome
• Markedly elevated levels of androgens can produce
signs of virilization, most noticeably clitoromegaly, voice deepening and male
pattern balding
• Evidence of estrogen production includes a pink, moist vagina and cervical mucus
48. Testing
• The differential diagnosis of amenorrhea is extensive
• Testing may be modified by patient history and physical
examination
• All reproductive-aged women with amenorrhea are assumed
pregnant until proven otherwise.
• Thus, a urinary or serum β-hCG level is almost always obtained
49. the progesterone challenge test
• One regimen is medroxyprogesterone acetate(Provera) given as a 10-mg
daily oral dose for 10 days
• Withdrawal bleeding …. woman is assumed to produce estrogen and
to have a developed endometrium and patent out flow tract
• No withdrawal bleeding …. estrogen progesterone test
• If a woman again fails to bleed several days after
completing the 21 hormone-containing pills, then an anatomic
abnormality is diagnosed
• Is there chance of incorrect test?
50. …
• Specifically, up to 20 percent of women in whom estrogen is present
will fail to bleed following progesterone withdrawal
• Conversely, menses may be observed after progesterone
administration in up to 40 percent of women with hypothalamic
amenorrhea due to stress, weight loss, or exercise and in up
to 50 percent of women with POF
51. Serum Hormone Levels
• For any woman found to have a normal pelvic examination
1. Serum β-hCG
2. TSH
3. FSH
4. Prolactin
52.
53.
54. TREATMENT
• Treatment of amenorrhea depends on its etiology and
patient goals such as a desire to treat hirsutism or seek pregnancy.
• Anatomic abnormalities often require surgical correction
• Hypothyroidism …. levothyroxine is 1.6 µg/kg/day…recheck after 6-
8weeks
• Hyperprolactinemia…. dopamine agonist, such as bromocriptine or
cabergoline
55. Estrogen Replacement
• This therapy is instituted in essentially every patient with
hypogonadism to avoid osteoporosis
• C/I…estrogen-sensitive tumor
• Women with a uterus also require continuous or intermittent
progesterone administration to protect against endometrial
hyperplasia or cancer
• Frequently, it is easiest to prescribe COCs.
• For most individuals, continuation until approximately
age 50, the usual age of menopause, seems reasonable
57. Infertility
• POF is not reversible, and affected individuals can be offered in vitro
fertilization using a donor oocyte to conceive
• Women with PCOS will frequently ovulate
following treatment with the selective estrogen-receptor modulator
clomiphene citrate, or with an aromatase inhibitor such
as letrozole.
• Clomiphene citrate is believed to act by transient inhibition of
estrogen feedback at the hypothalamus and pituitary gland
58. Patient education
• Patients are adequately counseled regarding their diagnosis,
its long-term implications, and treatment options.
• All women with an intact endometrium must understand the risks of
unopposed estrogen action, whether the estrogen is exogenous,
such as through hormone therapy, or endogenous, such as
in PCOS.
• For hypoestrogenic women, clinicians explain the importance of estrogen
replacement to protect against bone
loss.
• Last, even if not raised by the patient, the potential or lack of potential for
future child-bearing is discussed
Editor's Notes
Of course, amenorrhea is a normal state prior to puberty, duringpregnancy and lactation, continuous administration COCs and following menopause.
End-stage kidney disease is associated with increased serum prolactin and altered leptin levels, both of which may disruptnormal GnRH pulsatility. primary hypothyroidism may result in mildly elevated prolactin levels
Importantly, recent advances in oocyte and ovarian tissue cryopreservation make it likely that oocyte harvestprior to treatment will become the preferred approach when feasible
CRH alters the pattern of pulsatile GnRH secretion, whereas cortisol may act directly or indirectly to disrupt GnRH neuronal function
Leptin is produced from fat cells and makes you feel full
Pituitary apoplexy is characterized by a sudden onset of headache, nausea, visual deficits, and hormonal dysfunction dueto acute hemorrhage or infarction within the pituitary. Pituitary cell types are differentially sensitive to damage.
Pituitary tumors may impinge
on the optic chiasm, resulting in bitemporal hemianopsia, that is, the loss of both right and left outer visual fields
Low estrogen levels also manifest with a pale, thin,unrugated vagina.